JPH0417932B2 - - Google Patents

Info

Publication number
JPH0417932B2
JPH0417932B2 JP60504334A JP50433485A JPH0417932B2 JP H0417932 B2 JPH0417932 B2 JP H0417932B2 JP 60504334 A JP60504334 A JP 60504334A JP 50433485 A JP50433485 A JP 50433485A JP H0417932 B2 JPH0417932 B2 JP H0417932B2
Authority
JP
Japan
Prior art keywords
nifedipine
mixture
release
treatment
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60504334A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62500660A (ja
Inventor
Bitsutorio Jiudaisu
Bitsutorino Raberii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUAAMATETSUKU SpA
Original Assignee
FUAAMATETSUKU SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11199169&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0417932(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by FUAAMATETSUKU SpA filed Critical FUAAMATETSUKU SpA
Publication of JPS62500660A publication Critical patent/JPS62500660A/ja
Publication of JPH0417932B2 publication Critical patent/JPH0417932B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Surgical Instruments (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
JP60504334A 1984-09-14 1985-09-04 活性物質の制御放出を伴うニフェディピンを基礎とする内服用固体の製造方法 Granted JPS62500660A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22678/84A IT1178511B (it) 1984-09-14 1984-09-14 Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT22678A/84 1984-09-14

Publications (2)

Publication Number Publication Date
JPS62500660A JPS62500660A (ja) 1987-03-19
JPH0417932B2 true JPH0417932B2 (enEXAMPLES) 1992-03-26

Family

ID=11199169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60504334A Granted JPS62500660A (ja) 1984-09-14 1985-09-04 活性物質の制御放出を伴うニフェディピンを基礎とする内服用固体の製造方法

Country Status (16)

Country Link
EP (1) EP0226588B1 (enEXAMPLES)
JP (1) JPS62500660A (enEXAMPLES)
AT (1) ATE61733T1 (enEXAMPLES)
AU (1) AU588258B2 (enEXAMPLES)
CA (1) CA1253079A (enEXAMPLES)
DE (1) DE3582251D1 (enEXAMPLES)
DK (1) DK172710B1 (enEXAMPLES)
ES (1) ES8702137A1 (enEXAMPLES)
FI (1) FI87991C (enEXAMPLES)
IE (1) IE58490B1 (enEXAMPLES)
IT (1) IT1178511B (enEXAMPLES)
NO (1) NO171887C (enEXAMPLES)
PT (1) PT81113B (enEXAMPLES)
WO (1) WO1986001717A1 (enEXAMPLES)
YU (1) YU45988B (enEXAMPLES)
ZA (1) ZA856862B (enEXAMPLES)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
US7060293B1 (en) 1994-05-25 2006-06-13 Purdue Pharma Powder-layered oral dosage forms
DK0800392T3 (da) * 1994-12-29 2002-03-18 Shire Deutschland Gmbh & Co Kg Farmaceutiske præparater med indhold af nifedipin samt fremgangsmåde til fremstilling deraf

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation

Also Published As

Publication number Publication date
EP0226588A1 (en) 1987-07-01
WO1986001717A1 (en) 1986-03-27
ES8702137A1 (es) 1987-01-16
IT8422678A0 (it) 1984-09-14
DK222186D0 (da) 1986-05-13
FI87991B (fi) 1992-12-15
DK222186A (da) 1986-05-13
IE58490B1 (en) 1993-09-22
FI87991C (fi) 1993-03-25
CA1253079A (en) 1989-04-25
IE852262L (en) 1986-03-14
JPS62500660A (ja) 1987-03-19
FI871116A7 (fi) 1987-03-13
FI871116A0 (fi) 1987-03-13
NO171887C (no) 1993-05-19
DK172710B1 (da) 1999-06-07
DE3582251D1 (de) 1991-04-25
AU588258B2 (en) 1989-09-14
PT81113A (en) 1985-10-01
ZA856862B (en) 1986-05-28
EP0226588B1 (en) 1991-03-20
NO861845L (no) 1986-05-07
PT81113B (pt) 1987-10-20
YU45988B (sh) 1992-12-21
AU4959485A (en) 1986-04-08
YU143985A (en) 1987-10-31
ES547707A0 (es) 1987-01-16
IT1178511B (it) 1987-09-09
NO171887B (no) 1993-02-08
ATE61733T1 (de) 1991-04-15

Similar Documents

Publication Publication Date Title
JP7627302B2 (ja) パルボシクリブの固形剤形
EP0164959B1 (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
US5405619A (en) Controlled release therapeutic system for liquid pharmaceutical formulations
DE69013473T2 (de) Cimetidin enthaltende Arzneimittel.
CN100352432C (zh) 含有那格列奈的制剂
EP0312340A1 (en) Use of carbomer in controlled-release formulations to enhance or increase the dissolution rate of poorly soluble pharmacologically active substances
JPH08501081A (ja) 制御放出モルヒネ製剤
JPH10502629A (ja) 懸濁液中のモグイステインの制御放出のための薬剤組成物
JP2001511156A (ja) 高いバイオアベイラビリティーを有するフェノフィブレート医薬組成物及びそれを調製するための方法
JPH0417932B2 (enEXAMPLES)
JPS6238323B2 (enEXAMPLES)
EP0013263A2 (en) A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof
SK278868B6 (sk) Prípravok s retardovaným uvoľňovaním účinnej látky
GB2159715A (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
JP4754485B2 (ja) 共沈活性物質含有粒子
JP2024528260A (ja) 難溶性薬物の浸透圧ポンプ制御放出錠剤及びその製造方法
JPH01313431A (ja) ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
CN108309949B (zh) 一种吗啡渗透泵片的制备方法及其产品
CN116687961B (zh) 一种含有兰索拉唑及碳酸氢钠的干混悬剂及其制备方法
CN100420437C (zh) 磷酸川芎嗪缓释微丸及制备方法
WO1997039747A1 (en) Taste masked paracetamol compositions
DE3903217A1 (de) Verfahren zur herstellung fester pharmazeutischer zubereitungen
JP3412899B2 (ja) 徐放性細粒剤およびその製造方法
RU2289422C2 (ru) Фармацевтическая композиция на основе ноопепта